INOVIQ Ltd (ASX:IIQ) Insider Philip (Phil) Powell Buys 50,000 Shares of Stock

INOVIQ Ltd (ASX:IIQ) insider Philip (Phil) Powell acquired 50,000 shares of the company’s stock in a transaction dated Monday, March 10th. The shares were bought at an average cost of A$0.35 ($0.22) per share, with a total value of A$17,500.00 ($11,075.95).

INOVIQ Stock Performance

The company has a current ratio of 7.07, a quick ratio of 9.52 and a debt-to-equity ratio of 2.02. The company has a market cap of $47.40 million, a P/E ratio of -6.02 and a beta of 2.04.

About INOVIQ

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.